Form 4: Veracyte VP, Chief Accounting Officer Reports Routine Stock Transaction for Tax Withholding

Veracyte, Inc.'s VP, Chief Accounting Officer, Jonathan Wygant, reported a disposition of 1,848 shares of common stock valued at $26.74 per share, solely for tax withholding purposes related to the vesting of Restricted Stock Units.

Summary

• Jonathan Wygant, Veracyte, Inc.'s VP, Chief Accounting Officer, filed a Form 4 reporting a transaction on June 2, 2025.
• The transaction involved the disposition of 1,848 shares of Veracyte Common Stock at a price of $26.74 per share.
• This disposition was identified with transaction code 'F', indicating shares were withheld to satisfy tax withholding obligations.
• The shares were withheld in connection with the vesting of 750, 713, 677, and 1,496 Restricted Stock Units (RSUs) granted on February 22, 2022, August 5, 2022, March 6, 2023, and March 6, 2024, respectively.
• The filing explicitly states that this transaction does not represent a sale by the reporting person.
• Following this transaction, Jonathan Wygant beneficially owns 47,915 shares of Veracyte Common Stock directly.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine administrative filing (Form 4) detailing a non-discretionary transaction (tax withholding for RSU vesting) by an insider. It does not indicate any significant positive or negative operational or financial news for the company.

Positives

• The transaction is a routine tax withholding event related to RSU vesting, indicating the fulfillment of compensation agreements.
• The filing explicitly clarifies that the disposition was not a discretionary sale by the insider, which can be viewed positively as it doesn't signal a lack of confidence in the company.

Negatives

• No direct negative implications for the company are present in this routine administrative filing.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic outlook.

Management Comments

• The reporting person is reporting the withholding of 1,848 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 750, 713, 677 and 1,496 Restricted Stock Units granted on February 22, 2022, August 5, 2022, March 6, 2023 and March 6, 2024, respectively, and does not represent a sale by the reporting person.

Industry Context

This specific filing is a routine insider transaction report and does not provide broader industry context or trends. It reflects standard compensation practices within publicly traded companies, particularly regarding equity awards like RSUs.

Stakeholder Impact

• Shareholders: The disposition of shares for tax withholding is a standard practice and does not typically have a significant direct impact on existing shareholders. It is a consequence of RSU vesting, which is part of the company's compensation strategy.

Key Dates

Keywords

Veracyte, VCYT, SEC Form 4, Insider Transaction, Stock Ownership, Restricted Stock Units, RSU Vesting, Tax Withholding, Jonathan Wygant, Beneficial Ownership